Home › Funds › Stonepine Capital Management, LLC › MSLE
Stonepine Capital Management, LLC position in MSLE
SATELLOS BIOSCIENCE INC · Health Care
Stonepine Capital Management, LLC reported holding 455,058 shares of MSLE (SATELLOS BIOSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 2.97% of its reported portfolio and ranking #10 among its reported holdings. Stonepine Capital Management, LLC has disclosed MSLE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Stonepine Capital Management, LLC's MSLE position evolved
Stonepine Capital Management, LLC first disclosed a stake in MSLE in Q1 2026 at 100,000 shares (US$563K). The position peaked in Q3 2026 at 455,058 shares, worth US$3.9M. Across 3 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 455,058 shares valued at US$3.9M — a reduction of -36,566 shares quarter over quarter.. Notable position changes include a 392% increase in Q2 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 100.00K | $563.00K | New |
| Q2 2026 | 491.62K | $3.72M | Add |
| Q3 2026 | 455.06K | $3.87M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MSLE and 13F data
MSLE (SATELLOS BIOSCIENCE INC) is a Health Care company. 31 other funds we track also report a position in MSLE — the largest reported positions include Vivo Capital, LLC (US$6.9M), SPHERA FUNDS MANAGEMENT LTD. (US$5.1M), Avidity Partners Management LP (US$3.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MSLE
- Vivo Capital, LLC 813.67K sh · $6.92M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 652.59K sh · $5.07M · Q2 2026
- Avidity Partners Management LP 387.77K sh · $3.01M · Q2 2026
- Saturn V Capital Management LP 350.00K sh · $2.72M · Q2 2026
- Empery Asset Management, LP 107.10K sh · $832.70K · Q2 2026
- CRCM LP 68.06K sh · $578.51K · Q3 2026
More on Stonepine Capital Management, LLC
FAQ
How long has Stonepine Capital Management, LLC held MSLE?
Stonepine Capital Management, LLC has disclosed MSLE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Stonepine Capital Management, LLC's current position in MSLE?
As of Q3 2026, Stonepine Capital Management, LLC holds 455.06K shares of MSLE (SATELLOS BIOSCIENCE INC), valued at $3.87M, representing 2.97% of its reported portfolio and ranking #10.
Has Stonepine Capital Management, LLC been buying or selling MSLE?
In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC reduced its position in MSLE. The position peaked in Q3 2026 at 455.06K shares.
Which other funds hold MSLE?
Other major institutional holders of MSLE include Vivo Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., Avidity Partners Management LP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.